FABP5 and breast neoplasm: The high expression level of FABP5 in the aggressive RA-resistant TNBC cells, MDA-MB-231 and MDA-MB-468, correlates with the marked upregulation of FABP5 observed in human breast tumors, particularly in tumors categorized by its invasive properties as well as late stages of breast cancer [51, 52].